223 related articles for article (PubMed ID: 11569320)
1. Cervical cancer screening from Pap smear to human papillomavirus DNA testing.
Jin XW; Xu H
Compr Ther; 2001; 27(3):202-8. PubMed ID: 11569320
[TBL] [Abstract][Full Text] [Related]
2. Human papillomavirus triage of patients with atypical squamous cells of undetermined significance on cervical Papanicolaou smear.
Kirby TO; Huh WK; Partridge EE
Ann Acad Med Singap; 2003 Sep; 32(5):590-5; quiz 596. PubMed ID: 14626785
[TBL] [Abstract][Full Text] [Related]
3. The value of monitoring human papillomavirus DNA results for Papanicolaou tests diagnosed as atypical squamous cells of undetermined significance: a College of American Pathologists Q-Probes study of 68 institutions.
Tworek JA; Jones BA; Raab S; Clary KM; Walsh MK
Arch Pathol Lab Med; 2007 Oct; 131(10):1525-31. PubMed ID: 17922588
[TBL] [Abstract][Full Text] [Related]
4. Use of human papillomavirus DNA testing to compare equivocal cervical cytologic interpretations in the United States, Scandinavia, and the United Kingdom.
Scott DR; Hagmar B; Maddox P; Hjerpe A; Dillner J; Cuzick J; Sherman ME; Stoler MH; Kurman RJ; Kiviat NB; Manos MM; Schiffman M
Cancer; 2002 Feb; 96(1):14-20. PubMed ID: 11836698
[TBL] [Abstract][Full Text] [Related]
5. HPV for cervical cancer screening: is the era of the molecular pap smear upon us?
Stoler MH
J Histochem Cytochem; 2001 Sep; 49(9):1197-8. PubMed ID: 11511693
[TBL] [Abstract][Full Text] [Related]
6. [Cervical cancer screning: from cytology to HPV testing].
Wei LH
Zhonghua Fu Chan Ke Za Zhi; 2019 May; 54(5):289-292. PubMed ID: 31154708
[TBL] [Abstract][Full Text] [Related]
7. Rightsizing cervical cancer screening: comment on "Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone".
Sawaya GF
Arch Intern Med; 2010 Jun; 170(11):985-6. PubMed ID: 20548012
[No Abstract] [Full Text] [Related]
8. Improving the performance of reflex Human Papilloma Virus (HPV) testing in triaging women with atypical squamous cells of undetermined significance (ASCUS): A restrospective study in a tertiary hospital in United Arab Emirates (UAE).
Fakhreldin M; Elmasry K
Vaccine; 2016 Feb; 34(6):823-30. PubMed ID: 26747717
[TBL] [Abstract][Full Text] [Related]
9. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.
Cuzick J; Arbyn M; Sankaranarayanan R; Tsu V; Ronco G; Mayrand MH; Dillner J; Meijer CJ
Vaccine; 2008 Aug; 26 Suppl 10():K29-41. PubMed ID: 18847555
[TBL] [Abstract][Full Text] [Related]
10. [Screening of cervical cancer--update].
Dvorák V; Ondrus J
Ceska Gynekol; 2010 Feb; 75(1):65-8. PubMed ID: 20437841
[TBL] [Abstract][Full Text] [Related]
11. Benefits and costs of using HPV testing to screen for cervical cancer.
Mandelblatt JS; Lawrence WF; Womack SM; Jacobson D; Yi B; Hwang YT; Gold K; Barter J; Shah K
JAMA; 2002 May; 287(18):2372-81. PubMed ID: 11988058
[TBL] [Abstract][Full Text] [Related]
12. Can self vaginal douching for high risk HPV screening replace or assist efficacy of cervical cancer screening?
Suwannarurk K; Bhamarapravatana K; Kheolamai P; Thaweekul Y; Mairaing K; Poomtavorn Y; Pattaraarchachai J
Asian Pac J Cancer Prev; 2010; 11(5):1397-401. PubMed ID: 21198300
[TBL] [Abstract][Full Text] [Related]
13. The degree of agreement between HPV testing, pap smear and colposcopy in cervical dysplasia diagnosis.
Melinte-Popescu A; Costăchescu G
Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):536-9. PubMed ID: 23077949
[TBL] [Abstract][Full Text] [Related]
14. Hybrid Capture method for detection of human papillomavirus DNA in clinical specimens: a tool for clinical management of equivocal Pap smears and for population screening.
Lörincz AT
J Obstet Gynaecol Res; 1996 Dec; 22(6):629-36. PubMed ID: 9037955
[TBL] [Abstract][Full Text] [Related]
15. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
[TBL] [Abstract][Full Text] [Related]
16. New cervical cancer screening strategy: combined Pap and HPV testing.
Jin XW; Zanotti K; Yen-Lieberman B
Cleve Clin J Med; 2005 Feb; 72(2):141-8. PubMed ID: 15757169
[TBL] [Abstract][Full Text] [Related]
17. Knowledge and attitudes about human papillomavirus, Pap smears, and cervical cancer among young women in Brazil: implications for health education and prevention.
Moreira ED; Oliveira BG; Ferraz FM; Costa S; Costa Filho JO; Karic G
Int J Gynecol Cancer; 2006; 16(2):599-603. PubMed ID: 16681732
[TBL] [Abstract][Full Text] [Related]
18. Testing for human papillomavirus in women with abnormal pap smear results.
McCaffery KJ; Waller J; Forrest S; Wardle J
JAMA; 2002 Sep; 288(11):1350; author reply 1351-2. PubMed ID: 12234219
[No Abstract] [Full Text] [Related]
19. Detection of human papillomavirus DNA by the hybrid capture assay.
Carvalho MO; Almeida RW; Leite FM; Fellows IB; Teixeira MH; Oliveira LH; Cavalcanti SM
Braz J Infect Dis; 2003 Apr; 7(2):121-5. PubMed ID: 12959682
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness analysis of human papillomavirus DNA testing and Pap smear for cervical cancer screening in a publicly financed health-care system.
Chow IH; Tang CH; You SL; Liao CH; Chu TY; Chen CJ; Chen CA; Pwu RF
Br J Cancer; 2010 Dec; 103(12):1773-82. PubMed ID: 21102588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
